Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 26 04:00PM ET
7.45
Dollar change
-0.27
Percentage change
-3.50
%
Index- P/E- EPS (ttm)-1.12 Insider Own52.27% Shs Outstand8.29M Perf Week3.91%
Market Cap60.05M Forward P/E43.82 EPS next Y0.17 Insider Trans0.00% Shs Float3.85M Perf Month-10.51%
Income-9.30M PEG- EPS next Q0.03 Inst Own5.76% Short Float0.41% Perf Quarter-4.49%
Sales31.64M P/S1.90 EPS this Y121.93% Inst Trans-8.19% Short Ratio1.85 Perf Half Y41.37%
Book/sh-1.33 P/B- EPS next Y-32.00% ROA-14.16% Short Interest0.02M Perf Year26.92%
Cash/sh0.19 P/C39.25 EPS next 5Y- ROE129.20% 52W Range3.67 - 9.50 Perf YTD29.57%
Dividend Est.- P/FCF- EPS past 5Y-58.40% ROI- 52W High-21.56% Beta0.48
Dividend TTM- Quick Ratio0.49 Sales past 5Y1.57% Gross Margin71.33% 52W Low103.00% ATR (14)0.56
Dividend Ex-DateSep 01, 2022 Current Ratio0.52 EPS Y/Y TTM-512.90% Oper. Margin-0.82% RSI (14)46.51 Volatility5.09% 6.99%
Employees88 Debt/Eq- Sales Y/Y TTM1.93% Profit Margin-29.38% Recom1.00 Target Price11.00
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q200.75% Payout- Rel Volume1.35 Prev Close7.72
Sales Surprise-0.38% EPS Surprise60.00% Sales Q/Q3.48% EarningsJul 15 AMC Avg Volume8.44K Price7.45
SMA20-0.42% SMA50-9.24% SMA20014.59% Trades Volume11,380 Change-3.50%
Jul-15-24 04:30PM
Apr-15-24 05:00PM
Mar-25-24 09:00AM
Feb-28-24 05:00PM
Jan-22-24 04:15PM
04:45PM Loading…
Oct-12-23 04:45PM
Jul-14-23 04:15PM
Apr-21-23 04:15PM
Feb-28-23 05:15PM
Jan-24-23 11:00AM
Oct-14-22 04:15PM
Aug-22-22 06:00PM
Aug-17-22 05:00PM
Jul-11-22 04:30PM
Apr-13-22 04:30PM
04:30PM Loading…
Mar-16-22 04:30PM
Mar-09-22 04:15PM
Feb-22-22 04:30PM
Oct-27-21 04:15PM
Oct-15-21 04:36PM
Sep-20-21 06:05PM
Aug-30-21 09:00AM
Aug-20-21 09:04AM
Aug-11-21 12:03PM
09:00AM
Jul-15-21 07:27PM
May-10-21 09:00AM
Apr-14-21 06:14PM
Feb-26-21 09:30AM
Feb-24-21 04:30PM
04:39PM Loading…
Oct-15-20 04:39PM
Cryo-Cell International, Inc. is cord blood bank, which engages in providing stem cell cryopreservation services and advancing regenerative medicine. It operates through the following segments: Cellular Processing and Cryogenic Storage, and Prepacyte CB. The Cellular Processing and Cryogenic Storage segment focuses on the collection and preservation of umbilical cord blood and tissue stem cells for family use. The Prepacyte CB segment refers to the processing technology used to process umbilical cord blood stem cells. The company was founded in 1989 and is headquartered in Oldsmar, FL.